Table 1 Characteristics of patients who underwent colonoscopic polypectomy.
From: Risk of postpolypectomy bleeding in patients taking direct oral anticoagulants or clopidogrel
Variables | DOAC group (n = 131) | Clopidogrel group (n = 270) | p-value |
|---|---|---|---|
Age (year), mean ± SD | 71.7 ± 9.01 | 67.5 ± 9.34 | < 0.001 |
Male, n (%) | 100 (76.3) | 212 (78.5) | 0.622 |
Comorbidities, n (%) | |||
Respiratory disease | 16 (12.2) | 12 (4.4) | 0.004 |
Diabetes mellitus | 37 (28.2) | 88 (32.6) | 0.378 |
Hypertension | 86 (65.7) | 177 (65.6) | 0.985 |
Atrial fibrillation | 121 (92.4) | 14 (5.2) | < 0.001 |
Coronary arterial disease | 25 (19.1) | 122 (45.2) | < 0.001 |
Cerebrovascular disease | 36 (27.5) | 65 (24.1) | 0.461 |
Chronic kidney disease | 7 (5.34) | 27 (10.0) | 0.116 |
Antithrombotic discontinuation before procedure, day, mean ± SD | 2.82 ± 1.74 | 5.84 ± 2.25 | < 0.001 |
Compliance with antithrombotic discontinuation guideline, n (%) | 0.181 | ||
Compliant | 112 (85.5) | 216 (80.0) | |
Noncompliant (shorter discontinuation than guideline) | 19 (14.5) | 54 (20.0) | |
Antithrombotic resumption after procedure, day, mean ± SD | 1.65 ± 2.89 | 1.66 ± 1.06 | 0.989 |
Delayed PPB, n (%) | 4 (3.1) | 8 (3.0) | > 0.999 |
Thromboembolic event with 4 weeks of the procedure, n (%) | 0 | 0 | NA |
